Proteomic

Because practice management systems and electronic health records originally were designed to support accurate billing for subsequent reimbursement, fundamental changes to practice patterns are slow to enter clinical practices.

The proteomic characterization of patients with chronic kidney disease allows for more generating mechanism-based hypotheses that could assist in future drug targeting, according to a speaker at American Society of Nephrology Kidney Week.

Researchers have identified “critical pathways” and “novel proteins” that may be considered potential drug targets for patients with epilepsy, according to findings published in bioRxiv.